Pharmaceutical Company AbbVie Inflated Prices for Two Major Drugs, House Oversight Report Says

The image shows a trojan horse outside the walls of a fortress.

CPG

Pricing Value Maps, CPG, and Trojan Horses

.Note: A version of this article appeared in our LinkedIn newsletter, Pricing Power Clarity®. The “classic” price value maps – refresher & setup In my “part 1” of this post I

March 6, 2023

Image shows logos of consumer brands like Nike, Tesla, Amazon and others on a map with an entry point and a destination marked by a grey cross.

Consumer Brands Pricing

Consumer Brands: Pricing Power Moves for Higher Profits

Note: A version of this article was published in our LinkedIn newsletter, Pricing Power Clarity®. Pricing power – defined broadly In our previous newsletter installments, we proposed expanding the accepted meaning

February 7, 2023

Tesla Pricing Strategy

Tesla’s Pricing Strategy: A Taxpayer Subsidy Beggar?

Note: A version of this article is submitted for publication on Seeking Alpha, the world’s largest investor site, where I occasionally contribute on companies that make consequential pricing strategy decisions. Summary

January 14, 2023

Pharmaceutical Company AbbVie Inflated Prices for Two Major Drugs, House Oversight Report Says

Recent Posts

EBITDA Catalyst^®, Pricing Power Clarity^®, Mission Driven Pricing^® and Pricing as a System^® are registered trademarks of EBITDA Catalyst.
© 2022 EBITDA Catalyst | All Rights Reserved.

Pharmaceutical Company AbbVie Inflated Prices for Two Major Drugs, House Oversight Report Says

Recent Posts

Pricing Value Maps, CPG, and Trojan Horses

Consumer Brands: Pricing Power Moves for Higher Profits

Tesla’s Pricing Strategy: A Taxpayer Subsidy Beggar?

EBITDA Catalyst®, Pricing Power Clarity®, Mission Driven Pricing® and Pricing as a System® are registered trademarks of EBITDA Catalyst. © 2022 EBITDA Catalyst | All Rights Reserved.

EBITDA Catalyst^®, Pricing Power Clarity^®, Mission Driven Pricing^® and Pricing as a System^® are registered trademarks of EBITDA Catalyst.
© 2022 EBITDA Catalyst | All Rights Reserved.